Lipid regulation and metabolism in myelin repair
Lipid regulation and metabolism in myelin repair
批准号:
10242613
负责人:
Meredith D Hartley
金额:
$13.9万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-15 至 2022-06-30
关键词:
AddressAdultAffectAgeAgonistApplications GrantsAreaBiological AssayBiological MarkersBrainCell DeathCell Differentiation processCell membraneCellsCholesterol HomeostasisCorpus CallosumCuprizoneDataDemyelinationsDevelopmentDiseaseDisease PathwayEnterobacteria phage P1 Cre recombinaseFamilyFatty AcidsFutureGene Expression RegulationGenesGeneticGenetic TranscriptionGoalsHormonesHourHumanImmune systemIncubatedKnowledgeLaboratoriesLaboratory StudyLecithinLesionLigandsLipidsMapsMass Spectrum AnalysisMeasuresMediator of activation proteinMetabolismModelingMolecular AnalysisMotorMultiple SclerosisMusMyelinNeurologicNuclear Hormone ReceptorsNuclear ReceptorsOleic AcidsOligodendrogliaOutcomePathway interactionsPeripheralPharmaceutical PreparationsPhasePhenotypePhysiologicalPlayPopulationProcessPublishingRecoveryRegulationResearchResolutionRoleRotarod Performance TestSpinal CordStainsSterolsSymptomsTachycardiaTamoxifenTechnologyTherapeutic InterventionThyroid Hormone ReceptorThyroid HormonesTissue SampleToxinTranscriptional RegulationTriglyceride Metabolismbasebrain tissueconditional knockoutdisabilitydrug candidateexperimental studyhigh throughput screeningimaging approachinnovationinterestlipid metabolismlysophosphatidic acidmotor disordermotor recoverymouse modelmyelinationnervous system disordernew therapeutic targetnovel therapeuticsoligodendrocyte progenitorreceptorremyelinationrepairedside effectstem cellstargeted agenttranscriptome sequencingtranscriptomicswhite matter
中文摘要
目前所有可用于治疗多发性硬化症的疗法都是抗炎药,
免疫系统,目前还没有批准的药物来促进脱髓鞘损伤的修复,这是
神经功能障碍的根本原因。我们的长期目标是定义中枢神经系统脂类的调节方式
通过大脑荷尔蒙的变化以及这如何影响神经疾病。这个项目的总体目标是
应用,这是实现我们的长期目标的第一步,是识别与脂质相关的基因,
在重新髓鞘形成过程中是重要的,并定义了脂体在脱髓鞘和
重新髓鞘形成。我们的中心假设是荷尔蒙通过转录促进髓鞘形成
调节与脂类代谢有关的基因,而调节脂类是成功的关键
重新髓鞘形成。我们的假设是基于研究表明,甲状腺激素
调节大脑和少突胶质前体细胞(OPC)分化过程中的脂质相关基因,
这是髓鞘形成的重要一步。此外,几种脂类包括甾醇和
溶血磷脂酸与髓鞘再生有关。支持建议的
研究表明,它将为促进髓鞘修复的新疗法的开发确定脂质途径。
中心假说将根据以下两个具体目标进行评估:(1)识别与血脂相关的基因
受核受体调节,是OPC分化所必需的;和(2)MAP髓鞘脂类变化
重新髓鞘形成。在第一个目标中,将使用OPC分化分析来评估一组核
与髓鞘形成有关的受体配体。然后进行RNA测序,以确定
参与OPC分化和膜过程延长的脂质相关基因。对于第二个目的,
脑脂将从可诱导的条件性基因敲除小鼠脱髓鞘模型中分离出来
Plp-Creert;Myrffl/fl菌株。将进行质谱分析以描述大脑脂肪组
病程中脱髓鞘和再髓鞘阶段的变化。拟议的研究是
申请人认为,这是一种创新,因为使用了两种正交方法来协同
确定在重新髓鞘形成过程中重要的新的脂质途径。在完成这项拟议的研究后,
预计将确定参与中枢神经系统髓鞘再分化的一个或多个脂质途径。这一贡献
预计将具有重大意义,因为它将增加人们对脂类如何在
重新髓鞘形成,并可能揭示一个新的靶点的治疗干预影响的疾病
脱髓鞘。这些研究还将为竞争性R01赠款提供必要的初步数据
在未来的应用。
英文摘要
All of the current therapies available for treating multiple sclerosis are anti-infllammatory agents that target
the immune system, and there are no approved drugs that promote repair of demyelinated lesions, which is
the underlying cause of neurological disability. Our long-term goal is to define how CNS lipids are regulated
by changes in brain hormones and how this affects neurological disease. The overall objective in this
application, which is the first step toward achieving our long-term goal, is to identify lipid-related genes that
are important during remyelination and define how the lipidome changes during demyelination and
remyelination. Our central hypothesis is that hormones promote myelination through transcriptional
regulation of genes involved in lipid metabolism, and that regulation of lipids is critical for successful
remyelination. Our hypotheses have been formulated based on studies showing that thyroid hormone
regulates lipid-related genes in the brain and during oligodendrocyte progenitor cell (OPC) differentiation,
which is an important step in myelination. In addition, several lipid classes including sterols and
lysophosphatidic acids have been implicated in remyelination. The rationale that supports the proposed
research is that it will identify lipid pathways for the development of new therapies for promoting myelin repair.
The central hypothesis will be evaluated with the two following specific aims: (1) Identify lipid-related genes
regulated by nuclear receptors and required for OPC differentiation; and (2) Map myelin lipid changes during
remyelination. In the first aim, an OPC differentiation assay will be used to evaluate a panel of nuclear
receptor ligands that have been implicated in myelination. RNA-sequencing will then be performed to identify
lipid-related genes involved in OPC differentiation and membrane process extension. For the second aim,
brain lipids will be isolated from an inducible conditional knockout mouse model of demyelination based on
the Plp-CreERT;Myrffl/fl strain. Mass spectrometry analysis will be performed to profile the brain lipidomic
changes in demyelinating and remyelinating phases of the disease course. The proposed research is
innovative, in the applicant’s opinion, because two orthogonal approaches are being used to synergistically
identify new lipid pathways of importance in remyelination. Upon completion of this proposed research, it is
expected that one or more lipid pathways involved in CNS remyelination will be identified. This contribution
is expected to be significant, because it will increase knowledge about how lipids are regulated during
remyelination and may reveal a novel target for therapeutic intervention in diseases affected by
demyelination. These studies will also provide necessary preliminary data for a competitive R01 grant
application in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipid regulation and metabolism in myelin repair
-
批准号:10434463
-
项目类别:
-
资助金额:$21.68万
-
财政年份:2020
-
负责人:Meredith D Hartley
-
依托单位:
Lipid regulation and metabolism in myelin repair
-
批准号:10203373
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2020
-
负责人:Meredith D Hartley
-
依托单位:
海外基金